The effect of Oncotype DX ® on adjuvant chemotherapy treatment decisions in early breast cancer.
CONCLUSIONS: In intermediate risk patients with breast cancer, the results of the ODX gene assay may change the decision for adjuvant treatment. It represents a valuable tool to assist patients' and clinicians' decision making regarding adjuvant chemotherapy.
PMID: 31219316 [PubMed - as supplied by publisher]
Source: Annals of the Royal College of Surgeons of England - Category: Surgery Authors: Rabie MA, Rankin A, Burger A, Youssef M Tags: Ann R Coll Surg Engl Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Genetics | Royal College of Surgeons | Study | Surgery